🇺🇸 FDA
Patent

US 10406194

Powder formulation, method for preparing the same and use thereof

granted A61KA61K2236/331A61K2236/51

Quick answer

US patent 10406194 (Powder formulation, method for preparing the same and use thereof) held by INFINITUS (CHINA) COMPANY LTD. expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INFINITUS (CHINA) COMPANY LTD.
Grant date
Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2236/331, A61K2236/51, A61K31/185, A61K31/733